PubMed:24691501 / 0-226 JSONTXT

{"project":"c_corpus","denotations":[{"id":"T1","span":{"begin":18,"end":28},"obj":"SO:1000009"},{"id":"T4","span":{"begin":32,"end":56},"obj":"D002285"},{"id":"T5","span":{"begin":32,"end":56},"obj":"D002285"},{"id":"T10","span":{"begin":69,"end":85},"obj":"D044584"},{"id":"T11","span":{"begin":69,"end":85},"obj":"D044584"},{"id":"T14","span":{"begin":91,"end":97},"obj":"CVCL_E024"},{"id":"T18","span":{"begin":98,"end":107},"obj":"11253"},{"id":"T16","span":{"begin":98,"end":107},"obj":"CHEBI:89324"},{"id":"T17","span":{"begin":98,"end":107},"obj":"D014807"},{"id":"T19","span":{"begin":98,"end":107},"obj":"D014807"},{"id":"T20","span":{"begin":98,"end":107},"obj":"CHEBI:27300"},{"id":"T23","span":{"begin":123,"end":140},"obj":"D002278"},{"id":"T24","span":{"begin":123,"end":140},"obj":"D002278"},{"id":"T26","span":{"begin":142,"end":146},"obj":"CVCL_5552"},{"id":"T25","span":{"begin":142,"end":146},"obj":"D002285"},{"id":"T27","span":{"begin":142,"end":146},"obj":"D002285"},{"id":"T28","span":{"begin":180,"end":186},"obj":"UBERON:0000310"}],"text":"Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analog.\nDuctal carcinoma in situ (DCIS) is a nonmalignant lesion of the breast with the potential to progress to invas"}

{"project":"Allie","denotations":[{"id":"SS1_24691501_1_0","span":{"begin":116,"end":140},"obj":"expanded"},{"id":"SS2_24691501_1_0","span":{"begin":142,"end":146},"obj":"abbr"}],"relations":[{"id":"AE1_24691501_1_0","pred":"abbreviatedTo","subj":"SS1_24691501_1_0","obj":"SS2_24691501_1_0"}],"text":"Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analog.\nDuctal carcinoma in situ (DCIS) is a nonmalignant lesion of the breast with the potential to progress to invas"}

{"project":"UseCases_ArguminSci_Discourse","denotations":[{"id":"T1","span":{"begin":0,"end":115},"obj":"DRI_Background"}],"text":"Inhibition of the transition of ductal carcinoma in situ to invasive ductal carcinoma by a Gemini vitamin D analog.\nDuctal carcinoma in situ (DCIS) is a nonmalignant lesion of the breast with the potential to progress to invas"}